Cytokines as Immune Effector Molecules in Autoimmune Endocrine Diseases with Special Reference to Insulin-Dependent Diabetes Mellitus

References

• Mandrup-Poulsen T, Bendtzen K, Nielsen J H, Bendixen G, Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 1985; 40: 424–429
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg J, Nielsen J H. Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy 1986; 41: 250–259
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Nerup J. The autoimmune hypothesis of type I diabetes: 1965 to the present. Autoimmunity and the pathogenesis of diabetes, F Ginsberg-Fellner, R C McEvoy. Springer Verlag, New York 1988, (in press)
   Google Scholar
• Laupacis A, Stiller C R, Gardell C, Keown P, Dupre J, Wallace A C, Thibert P. Cyclosporin prevents diabetes in BB Wistar rats. Lancet 1983; i: 10–12
   Google Scholar
• Mori Y, Suko M, Okudaira H, Matsuba I, Tsuruoka A, Sasaki A, Yokoyama H, Tanase T, Nishimura M, Terada E, Ikeda Y. Preventative effects of Cyclosporin on diabetes in NOD mice. Diabetologia 1986; 29: 244–247
   PubMedGoogle Scholar
• Feutren G, Papoz L, Assan R, Vialettes B, Karsenty G, Vexiau P, Rostu H D, Rodier M, Sirmai J, Lallemand A, Bach J-F. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet 1986; ii: 119–123
   Google Scholar
• Canadian-European Randomized Control Trial Group. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. Diabetes 1988; 37: 1574–1582
   Google Scholar
• Nerup J, Mandrup-Poulsen T, Mølvig J. The HLA-IDDM association: Implications for etiology and pathogenesis of IDDM. Diabetes/Metabolism Rev 1987; 3: 779–802
   PubMed Web of Science ®Google Scholar
• Spinas G A, Mandrup-Poulsen T, Mølvig J, Bæk L, Bendtzen K, Dinarello C A, Nerup J. Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans. Acta Endocrinol (Copenh) 1986; 113: 551–558
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello C A, Svenson M, Nielsen J H. Affinity-purified human Interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63–67
   PubMed Web of Science ®Google Scholar
• Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen J H, Dinarello C A, Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545–1547
   PubMed Web of Science ®Google Scholar
• Spinas G A, Hansen B S, Linde S, Kastern W, Mølvig J, Mandrup-Poulsen T, Dinarello C A, Nielsen J H, Nerup J. Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 1987; 30: 474–480
   PubMed Web of Science ®Google Scholar
• Sandler S, Andersson A, Hellerström C. Inhibitory effects of interleukin-1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinol 1987; 121: 1424–1431
   PubMed Web of Science ®Google Scholar
• Zawalich W S, Diaz V A. Interleukin 1 inhibits insulin secretion from isolated perifused rat islets. Diabetes 1986; 35: 1119–1123
   PubMed Web of Science ®Google Scholar
• Coraens P G, Wolf B A, Unanue E R, Lacy P E, McDaniel M L. Interleukin-1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes 1987; 36: 963–970
   Google Scholar
• Spinas G A, Palmer J P, Mandrup-Poulsen T, Andersen H U, Nielsen J H, Nerup J. The bimodal effect of interleukin 1 on rat pancreatic beta-cells—stimulation followed by inhibition—depends upon dose, duration of exposure and ambient glucose concentration. Acta Endocrinol (Copenh) 1988; 119: 307–11
   PubMedGoogle Scholar
• Khatim M S, Bahr G M, Gumaa K A, Behbehani K. Effect of recombinant IL-1 isomers on fetal and adult islet cell function and replication. Diab Res 1988; 8: 25–9
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Bendtzen K, Dinarello C A, Nerup J. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell toxicity. J Immunol 1987; 139: 4077–4082
   PubMed Web of Science ®Google Scholar
• Eizirik D L. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol (Copenh) 1988; 119: 321–325
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Bendtzen K, Dinarello C A, Nerup J. Interleukin 1 (IL-1) mediated pancreatic beta-cell killing: Potentiating effect of tumor necrosis factor (TNF). Diabetes 1987; 36(suppl 1)40A
   Google Scholar
• Campbell I L, Iscaro A, Harrison L C. IFN-γ and tumor necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J Immunol 1988; 141: 2325–2329
   PubMed Web of Science ®Google Scholar
• Pujol-Borell R, Todd I, Doshi M, Bottazzo G F, Sutton R, Gray D, Adolf G R, Feldmann M. HLA class II induction in human islet cells by interferon-y plus tumor necrosis factor or lymphotoxin. Nature 1987; 326: 304–306
   PubMedGoogle Scholar
• Mandrup-Poulsen T. On the pathogenesis of insulin-dependent diabetes mellitus. Thesis. Dan Med Bull 1988; 35: 438–60
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen J H, Dinarello C A. Ultrastructural study of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand (C) 1987; 95: 55–63
   Google Scholar
• Hansen B S, Nielsen J H, Linde S, Spinas G A, Welinder B S, Mandrup-Poulsen T, Nerup J. Effect of interleukin-1 on the biosynthesis of proinsulin and insulin in isolated rat pancreatic islets. Biomed Biochim Acta 1988; 47: 305–309
   PubMedGoogle Scholar
• Nerup J, Mandrup-Poulsen T, Mølvig J, Helqvist S, Wogensen L D, Egeberg J. Mechanisms of pancreatic β-cell destruction in type I diabeetes: An experimental model. Diab Care 1988; 11(suppl. 1)16–23
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Egeberg J, Bendtzen K, Dinarello C A, Nielsen J H, Nerup J. Morphological studies of isolated islets of Langerhans exposed to human interleukin-1. Diabetes 1988; 37: 19A
   Google Scholar
• Mandrup-Poulsen T, Spinas G A, Prowse S J, Hansen B S, Jørgensen D W, Bendtzen K, Nielsen J H, Nerup J. Islet cytotoxicity of interleukin 1: Influence of culture conditions and islet donor characteristics. Diabetes 1987; 36: 641–647
   PubMed Web of Science ®Google Scholar
• Spinas G A, Palmer J P, Egeberg J, Mandrup-Poulsen T, Andersen H U, Nielsen J H, Nerup J. Differential effects of interleukin-1 on pancreatic alpha and beta cells. Diabetes 1988; 37(suppl. 1)202A
   Google Scholar
• Rabinovitch A, Pukel C, Baquerizo H. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures. Endocrinol 1988; 122: 2393–2398
   PubMed Web of Science ®Google Scholar
• Eizirik D L, Strandell E, Bendtzen K, Sandler S. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1. Diabetes 1988; 37: 916–919
   PubMed Web of Science ®Google Scholar
• Eizirik D L, Sandler S. Functional restoration of cultured mouse pancreatic islets after in vitro exposure to alloxan. Pharmacol Toxicol 1988, (in press)
   Google Scholar
• Sims J E, March C J, Cosman D, Widmer M B, MacDonald H R, McMahan C J, Grubin C E, Wignall J M, Jackson J L, Call S M, Friend D, Alpert A R, Gillis S, Urdal D L, Dower S K. cDNA expression cloning of the IL-1 receptor, a membrane of the immunoglobulin superfamily. Science 1988; 241: 585–589
   PubMed Web of Science ®Google Scholar
• Andersen H U, Mandrup-Poulsen T, Egeberg J, Helqvist S, Nerup J. Genetically determined differences in newborn rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat. Acta Endocrinol (Copenh) 1989; 120: 92–98
   PubMedGoogle Scholar
• Kawahara D J, Everts M, Sandborg C, Berman M, Buckingham B. Cytokine-mediated killing of bovine islets is prevented by an interleukin-1 inhibitor. Diabetes 1988; 37(suppl. 1)19A
   Google Scholar
• Nielsen J H. Destruction of insulin producing cells by diabetogenic agents in vitro: Differences in susceptibility and mechanism of action. Immunology in Diabetes 84. International Symposium, RomeItaly, March, 15–171984
   Google Scholar
• Everts M, Plunkett J M, Buckingham B, Sandborg C, Berman M, Kershnar A, Kawahara D J. An IL-1 inhibitor (IL-li) prevents interleukin-1 (IL-1) islet cell destruction but does not prevent IL-1 suppression of insulin release. Diabetes 1988; 37(suppl. 1)56A
   Google Scholar
• Arend W P, Joslin F G, Massoni R J. Effects of immune complexes on production by human monocytes of interleukin-1 or an interleukin-1 inhibitor. J Immunol 1985; 134: 3868–75
   PubMed Web of Science ®Google Scholar
• Spinas G A, Palmer J P, Mandrup-Poulsen T, Andersen H, Nielsen J H, Nerup J. The bimodal effect of interleukin 1 on rat pancreatic β-cells—stimulation followed by inhibition—depends upon dose, duration of exposure, and ambient glucose concentration. Acta Endocrinol (Copenh) 1988; 118: 307–311
   Google Scholar
• Palmer J P, Helqvist S, Spinas G A, Mølvig J, Mandrup-Poulsen T, Andersen H U, Nerup J. The β-cell—A moving target? Interaction between pancreatic β-cell activity, IL-1 concentration and IL-1 exposure time on insulin secretion from isolated rat islets of Langerhans. Diabetes 1989, (in press)
   Google Scholar
• Helqvist S, Palmer J P, Andersen H U, Spinas G, Nerup J. The B cell—a moving target for immunological attack. Diabetologia 1988; 31: 500A
   Google Scholar
• West D B, Yataka S, Woods S C, Porte D. Ventromedial hypothalamic lesions increase pancreatic sensitivity to streptozotocin in rats. Diabetes 1980; 29: 948–951
   Google Scholar
• Eizirik D L, Strandell E, Sandler S. Culture of mouse pancreatic islets in different glucose concentrations modifies B cell sensitivity to streptozotocin. Diabetologia 1988; 31: 168–174
   PubMed Web of Science ®Google Scholar
• Portha B, Picon L. Insulin treatment improves the spontaneous remission of neonatal streptozotocin diabetes in the rat. Diabetes 1982; 31: 165–169
   Google Scholar
• Gotfredsen C F, Buschard K, Frandsen E K. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985; 28: 933–935
   PubMed Web of Science ®Google Scholar
• Shah S C, Malone J I, Simpson N E. Suppression of endogenous insulin secretion (EIS) in new onset insulin dependent diabetics (IDD) prolongs β-cell function. Diabetes 1987; 36(suppl. 1)61A
   Google Scholar
• The DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual β-cell function: observations during eligibility testing for the diabetes control and complications trial (DCCT). J Clin Endocrinol Metab 1987; 65: 29–36
   Google Scholar
• Amiel S A, Sherwin R S, Simonson D S, Lauritano A A, Tamborlane W V. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986; 315: 215–219
   PubMed Web of Science ®Google Scholar
• Volpé R, Karlsson A, Jansson R, Dahlberg P A. Evidence that antithyroid drugs induce remissions in Grave's disease by modulating thyroid cellular activity. Clin Endocrinol 1986; 25: 453–462
   PubMed Web of Science ®Google Scholar
• Greer M A, Kammer H, Bouma D J. Short-term antithyroid drug therapy for the thyrotoxicosis of Grave's Disease. N Engl J Med 1977; 297: 173–176
   Google Scholar
• Nielsen J H, Brunstedt K, Jensen D. Growth hormone is a potent growth factor for pancreatic beta-cells in vitro. Diabetes 1985; 34(suppl. 1)9A
   Google Scholar
• Rabinovitch A, Blondel B, Murray R, Mintz D H. Cyclic adenosine-3′,5′-monophosphate stimulates islet B cell replication in neonatal rat pancreatic monolayer cultures. J Clin Invest 1980; 66: 1065–1071
   Google Scholar
• Pipeleers D, Schuit F C, In't Veld P A, Maes E, Hooghe-Peters E L, Van De Winkel M, Gepts W. Interplay of nutrients and hormones in the regulation of insulin release. Endocrinol 1985; 117: 824–833
   PubMed Web of Science ®Google Scholar
• Nielsen J H, Mandrup-Poulsen T, Spinas G A, Hansen B S, Mølvig J, Nerup J, Bendtzen K. Possible role of interleukin-1 (IL-1) in the pathogenesis of insulin-dependent diabetes mellitus (IDDM). The immunology of diabetes mellitus. Excerpta Medica Int Congr Ser, M Jaworsky. Elsevier Press, Amsterdam 1986; 97–103, 717
   Google Scholar
• Leiter E. Murine macrophages and pancreatic beta-cells. Chemotactic properties of insulin and beta-cytostatic action of interleukin-1. J Exp Med 1987; 166: 1174–1179
   PubMed Web of Science ®Google Scholar
• Pukel C, Baquerizo H, Rabinovitch A. Leukocyte-associated polypeptides (cytokines) involved in cytolysis of islet cells in vitro. Diabetes 1988; 37: 7A
   Google Scholar
• Pukel C, Baquerizo H, Rabinovitch A. Destruction of rats islet cell monolayers by cytokines. Synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37: 133–136
   PubMed Web of Science ®Google Scholar
• Pipeleers D G, In't Veld P A, Van De Winkel M. Death of the pancreatic B-cell. The pathology of the endocrine pancreas in diabetes, D G Pipeleers, P J Lefebvre. Springer Verlag, Berlin 1988; 106–124
   Google Scholar
• Dower S K, Urdal D L. The interleukin-1 receptor. Immunol Today 1987; 8: 46–51
   PubMedGoogle Scholar
• Wogensen L D, Mandrup-Poulsen T, Markholst H, Mølvig J, Lernmark A, Hoist J J, Dinarello C A, Nerup J. Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas. Acta Endocrinol (Copenh) 1988; 117: 302–306
   PubMedGoogle Scholar
• Wogensen L D, Mandrup-Poulsen T, Nerup J. Recombinant human IL-1 potentiates glucose stimulated insulin release in the intact isolated perfused rat pancreas. Diabetologia 1988; 31: 560A
   Google Scholar
• Neufeld H A, Pace J G, Kaminski M V, George D T, Jahrling P B. A probable endocrine basis for the depression of ketone bodies during infectious or inflammatory state in rats. Endocrinology 1980; 107: 596–601
   Google Scholar
• Buchanan B J, Filkins J P. Insulin secretion and the carbohydrate metabolic alterations of endotoxaemia. Circ Shock 1976; 3: 267–280
   Google Scholar
• Blackard W G, Anderson J H, Spitzer J J. Hyperinsulinism in endotoxin shock dogs. Metabolism 1976; 25: 675–684
   Google Scholar
• Spitzer J J, Wagner G G, Blackard W G. Effects of glucose infusion on selected haemodynamic and metabolic variables and on plasma insulin concentrations in dogs after Escherichia coli endotoxin administration. Circ Shock 1976; 3: 31–38
   Google Scholar
• Rayfield E J, Curnow R T, Reinhard D, Kochicheril N M. Effects of acute endotoxinaemia on glucoregulation in normal and diabetic subjects. J Clin Endocrinol Metab 1977; 45: 513–521
   PubMed Web of Science ®Google Scholar
• Archer L T, White G L, Coalson J J, Beller B K, Elmore O, Hinshaw L B. Preserved liver function and leukocyte response in superlethal endotoxin shock. Circ Shock 1978; 5: 279–289
   Google Scholar
• Cornell R P. Endotoxin-induced hyperinsulinemia and hyperglucagonemia after experimental liver injury. Am J Physiol 1981; 241: E428–E435
   Google Scholar
• Cornell R P. Role of the liver in endotoxin-induced hyperinsulinemia and hyperglucagonemia in rats. Hepatology 1983; 3: 188–192
   Google Scholar
• Yelich M R, Filkins J P. Mechanisms of hyperinsulinemia in endotoxicosis. Am J Physiol 1980; 239: E156–E161
   PubMed Web of Science ®Google Scholar
• Yelich M R, Filkins J P. Role of calcium in the insulin hypersecretory state of the endotoxic rat pancreas. Circ Shock 1984; 14: 49–62
   Google Scholar
• Cornell R P. Endogeneous gut-derived bacterial endotoxin tonically primes pancreatic secretion of insulin in normal rats. Diabetes 1985; 34: 1253–1259
   PubMed Web of Science ®Google Scholar
• George D T, Abeles F B, Mapes C A, Sobocinski P Z, Zenser T V, Powanda M C. Effect of leucocytic endogeneous mediators on endocrine pancreas secretory responses. Am J Physiol 1977; 233: E240–E245
   Google Scholar
• Sacco-Gibson N, Filkins J P. Glucoregulatory effects of interleukin-1: Implications to the carbohydrate dyshomeostasis of septic shock. Perspectives in Shock Research, R F Bond, H R Adams, I H Chaudry. Alan R Liss, Inc., New York 1988; 355–360
   Google Scholar
• Pomposelli J J, Flores E A, Bistrian B R. Role of biochemical mediators in clinical nutrition and surgical metabolism. J Parenter Enter Nutr 1988; 12: 212–218
   PubMed Web of Science ®Google Scholar
• Zawalich W S, Zawalich K C. Interleukin-1 (IL-1) is a potent modulator of insulin secretion. Diabetes 1988; 37(suppl. 1)56A
   Google Scholar
• Endo Y, Suzuki R, Kumagai K. Interleukin-1-like factors can accumulate 5-hydroxytryptamine in the liver of mice and induce hypoglycemia. Biochim Biophys Acta 1985; 840: 37–42
   Google Scholar
• Del Ray A, Besedovsky H. Interleukin-1 affects glucose homeostasis. Am J Physiol 1987; 253: R794–R798
   Google Scholar
• Dinarello C A. Interleukin-1. Rev Infect Dis 1984; 6: 51–95
   PubMedGoogle Scholar
• Dinarello C A. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984; 311: 1413–1418
   PubMed Web of Science ®Google Scholar
• Goodman M, Wang Y, Lumerman J, Sussman K E, Lafferty K, Draznin B. In vivo administration of interleukin-1 inhibits insulin release in normal mice. Diabetes 1988; 37(suppl 1)6A
   Google Scholar
• Handler E S, Mordes J P, Seals J, Koevary S, Like A A, Nakano K, Rossini A A. Diabetes in the Bio-Breeding/Worcester rat. Induction and acceleration by spleen cell-conditioned media. J Clin Invest 1985; 76: 1692–1694
   Google Scholar
• Wright J R, Lacy P E. Synergistic effects of adjuvants, endtoxin, and fasting on induction of diabetes with multiple low doses of streptozotocin in rats. Diabetes 1988; 37: 112–118
   Google Scholar
• Flechner I, Muntefering H, Smadja Y, Laron Z. Immunomodulation of streptozotocin-induced diabetes in mice by a lipopolysaccharide. Diab Res 1984; 1: 231–232
   Google Scholar
• Kurt-Jones E A, Beller D I, Mizel S B, Unanue E R. Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci USA 1985; 82: 1204–1208
   PubMed Web of Science ®Google Scholar
• Kohan D E, Schreiner G F. Interleukin 1 modulation of renal epithelial glucose and amino acid transport. Am J Physiol 1988; 254
   Google Scholar
• McDaniel M L, Hughes J H, Wolf B A, Easom R A, Turk J W. Descriptive and mechanistic considerations of interleukin-1 and insulin secretion. Diabetes 1988; 37: 1311–15
   Google Scholar
• Wolf B A, Hughes J H, Florholmen J, Turk J. Mechanisms of recombinant interleukin-1 (rIL-1) inhibition of glucose-induced insulin secretion. Diabetes 1988; 37(suppl. 1)57A
   Google Scholar
• Abraham R T, Ho S N, Barna T J, McKean D J. Transmembrane signalling during interleukin 1-dependent T cell activation. J Biol Chem 1987; 262: 2719–2728
   PubMed Web of Science ®Google Scholar
• Rosoff P M, Savage N, Dinarello C A. Interleukin-1 stimulates diaglycerol production in T lymphocytes by a novel mechanism. Cell 1988; 54: 73–81
   PubMed Web of Science ®Google Scholar
• Best L, Malaisse W J. Phospholipids and islet function. Diabetologia 1983; 25: 299–305
   Google Scholar
• Metz S A. Glucose increases the synthesis of lipoxygenase-mediated metabolites of arachidonic acid in intact rat islets. Proc Natl Acad Sci USA 1985; 82: 198–202
   PubMedGoogle Scholar
• Morgan R O, Pek S B. Role of arachidonate lipoxygenase and cyclooxygenase product in insulin and glucagon secretion from rat pancreatic islets. Metabolism 1984; 33(10)928–935
   Google Scholar
• Zawalich W, Zawalich K. Effect of exogeneous phospholipase A2 on insulin secretion from perifused rat islets. Diabetes 1985; 34: 471–476
   PubMedGoogle Scholar
• Sandler S, Eizirik D L, Borg L AH, Strandell E, Welsh N, Bendtzen K. Studies on the mechanism causing the impairment of glucose-stimulated insulin release in rat pancreatic islets exposed to human recombinant interleukin-1β. Diabetologia 1988; 31: 539A
   Google Scholar
• Betteridge A. Role of Ca2+ and cyclic nucleotides in the control of prostaglandin E production in the rat anterior pituitary gland. Biochem J 1980; 186: 987–992
   Google Scholar
• Baracos V, Rodemann H P, Dinarello C A, Goldberg A L. Stimulation of muscle protein degradation and prostaglandin E2 release by leucocyte pyrogen (interleukin-1). A mechanism for the increased degradation of muscle protein during fever. N Eng J Med 1983; 308: 553–558
   PubMed Web of Science ®Google Scholar
• Klempner M S, Dinarello C A, Gallin J I. Human leucocytic pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest 1978; 61: 1330–1336
   PubMed Web of Science ®Google Scholar
• Myers R D. The role of ions in thermoregulation and fever. Pyretics and antipyretics, A S Milton. Springer Verlag, Berlin 1982; 151–86
   Google Scholar
• Devis G, Somers G, Malaisse W J. Stimulation of insulin release by calcium. Biochem Biophys Res Commun 1975; 67: 525–529
   Google Scholar
• Hellman B. Modifying actions of calciumionophores on insulin release. Biochim Biophys Acta 1975; 399: 157–169
   Google Scholar
• Schanne F AX, Kane A B, Young E E, Farber J L. Calcium dependence of toxic cell death: A final common pathway. Science 1979; 206: 699–702
   Google Scholar
• Endo Y, Matsushima K, Oppenheim J J. Mechanism of in vitro antitumor effects of interleukin 1 (IL 1). Immunobiol 1986; 172: 316–322
   PubMed Web of Science ®Google Scholar
• Matsubara T, Ziff M. Increased superoxide anion release from human endolethial cells in response to cytokines. J Immunol 1986; 137: 3295–3298
   PubMed Web of Science ®Google Scholar
• Pincus S H, Whitcomb E A, Dinarello C A. Interaction of IL-1 and TPA in modulation of eosinophil function. J Immunol 1986; 137: 3509–3514
   Google Scholar
• Eizirik D L, de Lucio M A, Boschero A C, Hoffman M E. Phenantroline, a metal chelator, protects against alloxan—but not streptozotocin-induced diabetes. J Fre Rad Biol Med. 1986; 2: 189–192
   PubMedGoogle Scholar
• Pipeleers D, Van de Winkel M. Pancreatic B cells posess defense mechanisms against cell-specific toxicity. Proc Natl Acad Sci USA 1986; 83: 5267–5271
   PubMed Web of Science ®Google Scholar
• Nerup J, Mandrup-Poulsen T, Mølvig J, Spinas G A. Immune interactions with islet cells: Implications for the pathogenesis of insulin-dependent diabetes mellitus. The pathology of the endocrine pancreas in diabetes, P Lefèbvre, D Pipeleers. Springer-Verlag, Berlin Heidelberg 1988; 71–84
   Google Scholar
• Nerup J, Mandrup-Poulsen T, Spinas G A, Mølvig J, Palmer J P, Wogensen L D, Helqvist S, Andersen H U, Nielsen J H. Pathogenesis of insulin-dependent diabetes mellitus and relevance for the transplant situation. Transplantation of the endocrine pancreas in diabetes mellitus, R V Schilfgaarde, M A Hardy. Elsevier Science Publishers B.V. 1989
   Google Scholar
• Nerup J, Mandrup-Poulsen T, Mølvig J, Helqvist S, Wogensen L D. On the pathogenesis of insulin dependent diabetes mellitus-A discussion of three recently proposed models. Diabetes Mellitus, W Creutzfeld, P J Lefèbvre, 1989; 39–50
   Google Scholar
• Thomsen M, Mølvig J, Zerbib A, Depreval C, Abbal M, Dugoujon J M, Ohayon E, Svejgaard A, Cambon Thomsen A, Nerup J. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3, 4 heterozygotes. Immunogenetics 1988; 28: 320–327
   PubMed Web of Science ®Google Scholar
• Todd J A, Bell J I, McDevitt H O. A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus. Trends in Genetics 1988; 4/5: 129–134
   Google Scholar
• Todd J A, Bell J I, McDevitt H O. HLA-DQ(beta) gene contributes to susceptibility and resistance to insulin-dependent mellitus. Nature 1987; 329: 599–604
   PubMed Web of Science ®Google Scholar
• Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 1988; 37: 1444–1448
   PubMed Web of Science ®Google Scholar
• Gepts W. Role of cellular immunity in the pathogenesis of type 1 diabetes. Curr Probl Clin Biochem 1983; 12: 86–99
   Google Scholar
• Eisenbarth G S. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360–1368
   PubMed Web of Science ®Google Scholar
• De Barardins P, Londei M, James R FL, Lake S P, Wise P H, Feldman M. Do CD4-positive cytotoxic T-cells damage islet β-cells in Type I diabetes. Lancet 1988; ii: 823–824
   Google Scholar
• Dinarello C A. Biology of interleukin 1. FASEB J 1988; 2: 108–115
   PubMed Web of Science ®Google Scholar
• Kolb H, Kantwerk G, Treichel U, Kürner T, Kiesel U, Hoppe T, Kolb-Bachofen V. Prospective analysis of islet lesions in BB rats. Diabetologia 1986; 29: 559A
   Google Scholar
• Dean B M, Walker R, Bone A J, Baird J D, Cooke A. Pre-diabetes in the spontaneously diabetic BB/E rat: Lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in the endocrine cells. Diabetologia 1985; 28: 464–466
   PubMed Web of Science ®Google Scholar
• Voorbij H AM, Jeucken P, Kabel P J, de Haan-Meulman, Drexhage H A. Dendritic cells in the development of diabetes mellitus in the BB rat. Diabetologia 1988; 31: 556A
   Google Scholar
• Scala G, Allavena P, Djeu J Y, Kasahara T, Ortaldo J R, Herberman R B, Oppenheim J J. Human large granular lymphocytes are potent producers of interleukin-1. Nature 1984; 309: 56–59
   PubMed Web of Science ®Google Scholar
• Peters P M, Ortaldo J R, Shalaby M R, Svedersky L P, Nedwin G E, Bringman T S, Hass P E, Aggarwal B B, Herberman R B, Goeddel D V, Palladino M S. Natural killer-sensitive targets stimulate production of TNF-α but not TNF-β (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol 1986; 137: 2592–2598
   PubMed Web of Science ®Google Scholar
• Baekkeskov S, Kanatsuna T, Klareskog L, Nielsen D A, Peterson P A, Rubinstein A H, Steiner D F, Lernmark Å. Expression of major histocompatibility antigens on pancreatic islet cells. Proc Natl Acad Sci USA 1981; 78: 6456–6460
   PubMed Web of Science ®Google Scholar
• Campbell I L, Wong G HW, Schrader J W, Harrison L C. Interferon-y enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells. Diabetes 1985; 34: 1205–1209
   PubMedGoogle Scholar
• Campbell I L, Bizilj K, Colman P G, Tuch B E, Harrison L C. Interferon-y induces the expression of HLA-A,B,C but not HLA-DR on human pancreatic β-cells. J Clin Endocrinol Metab 1986; 62: 1101–1109
   PubMedGoogle Scholar
• Campbell I L, Harrison L C, Colman P G, Papaioannou J, Ashcroft R G. Expression of class I MHC proteins on RIN-m5F cells is increased by interferon-y and lymphokine-conditioned medium. Diabetes 1986; 35: 1225–1228
   Google Scholar
• Issa-Chergui B, Goldner Sauve A, Colle E, Prud'homme G J, Lapcha, Van der Meide P H, Seemayer T A. Class I and II major histocompatility complex gene product expression by rat insulinoma cell in vitro following exposure to gamma interferon. Diabetologia 1988; 31: 675–680
   Google Scholar
• Wright J R, Lacy P E, Unanue E R, Muszynski C, Hauptfeld V. Interferon-mediated induction of Ia antigen expression on isolated murine whole islets and dispersed islet cells. Diabetes 1986; 35: 1174–1177
   Google Scholar
• Walker R, Cooke A, Bone A J, Dean B M, van der Meide P H, Baird J D. Induction of class II MHC antigens in vitro on pancreatic B cells isolated from BB/E rats. Diabetologia 1986; 29: 749–751
   Google Scholar
• van Vliet E, Molenaar J L, Tuk C W, Bruining G J, de Vries R RP. Recombinant gamma-interferon induces class II major histocompatibility complex antigens on insulinoma cells. Tissue Antigens 1987; 29: 195–200
   PubMed Web of Science ®Google Scholar
• Varey A M, Lydyard P M, Dean B M, van der Meide P H, Baird J D, Cooke A. Interferon-y induces class 11 MHC antigens on RINm5F cells. Diabetes 1988; 37: 209–212
   PubMed Web of Science ®Google Scholar
• Foulis A K, Farquharson M A, Hardman R. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in Type I (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 333–343
   PubMed Web of Science ®Google Scholar
• Dean B M, Walker R, Bone A J, Baird J D, Cooke A. Pre-diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetologia 1985; 28: 464–466
   PubMed Web of Science ®Google Scholar
• Pipeleers D G, In't Veld P A, Pipeleers-Marichal M A, Gepts W, van de Winkel M. Presence of pancreatic hormones in islet cells with MHC-class II antigen expression. Diabetes 1987; 36: 872–876
   Google Scholar
• In't Veld P A, Pipeleers D G. In situ analysis of pancreatic islets in rats developing diabetes. Appearance of nonendocrine cells with surface MHC class II antigens and cytoplasmic insulin immunoreactivity. J Clin Invest 1988; 82: 1123–1128
   Google Scholar
• Wright J R, Lacy P E, Unanue E R, Hauptfeld V. Induction of class II MHC antigens on human and rodent islet parenchymal cells in vitro. Diabetologia 1987; 30: 441
   Google Scholar
• Bottazzo G F, Pujol-Borrel R, Hanafusa T. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; ii: 1115–1118
   Google Scholar
• Rubinstein D, Roska A K, Lipsky P E. Liver sinusoidal lining cells express class II major histocompatibility antigens but are poor stimulators of fresh allogeneic T lymphocytes. J Immunol 1986; 137: 1803–1810
   PubMed Web of Science ®Google Scholar
• Geppert T D, Lipsky P E. Dissection of defective antigen presentation by interferon-y-treated fibroblasts. J Immunol 1987; 138: 385–392
   PubMed Web of Science ®Google Scholar
• Caspi R R, Roberge F G, Nussenblatt R B. Organ-resident non-lymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science 1987; 237: 1029–1032
   PubMed Web of Science ®Google Scholar
• Londei M, Lamb J R, Botazzo G F, Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 1984; 312: 639–641
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Gerstein H C, Iitaki M, Row V V, Volpé R. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. J Clin Endocrinol Metab 1986; 63: 695–708
   PubMed Web of Science ®Google Scholar
• Harel-Bellan A, Quillet A, Marchiol C, DeMars R, Tursz T, Fradelizi D. Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6. Proc Natl Acad SciUSA 1986; 83: 5688–5692
   PubMedGoogle Scholar
• Sarvetnick N, Liggit D, Pitts S L, Hansen S E, Stewart T A. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52: 773–782
   PubMed Web of Science ®Google Scholar
• Lo D, Burkly L C, Widera G, Cowing C, Flavell R A, Palmiter R D, Brinster R L. Diabetes and tolerance in transgenic mice expressing class II molecules in pancreatic beta cells. Cell 1988; 53: 159–168
   PubMed Web of Science ®Google Scholar
• Kroemer G, Brezinschek H P, Faessler R, Schauenstein K, Wick G. Physiology and pathology of an immunoendocrine loop. Immunol Today 1988; 9: 163–165
   PubMedGoogle Scholar
• Breder C D, Dinarello C A, Saper C B. Interleukin-1 immunoreactive innervation of the hypothalamus. Science 1988; 240: 321–324
   PubMed Web of Science ®Google Scholar
• Uehara A, Gottschall P E, Dahl R R, Arimura A. Stimulation of ACTH release by human interleukin-1β, but not by interleukin-1α, in conscious, freely moving rats. Biochem Biophys Res Comm 1987; 146: 1286–1290
   PubMed Web of Science ®Google Scholar
• Uehara A, Gillis S, Arimura A. Effects of interleukin-1 on hormone release from normal rat pituitary cells in primary culture. Neuroendocrinal 1987; 45: 343–347
   Google Scholar
• Bernton E W, Beach J E, Holaday J W, Smallridge R C, Fein H G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987; 238: 519–521
   PubMed Web of Science ®Google Scholar
• Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522–524
   PubMed Web of Science ®Google Scholar
• Berkenbosch F, Oers J V, deRay A, Tilders F, Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987; 238: 524–526
   PubMed Web of Science ®Google Scholar
• Uehara A, Gottschall P E, Dahl R R, Arimura A. Interleukin-1 stimulates ACTH release by an indirect action which requires endogeneous corticotropin releasing factor. Endocrinol 1987; 121: 1580–1582
   PubMedGoogle Scholar
• Katsuura G, Gottschall P E, Dahl R R, Arimura A. Adrenocorticotropin release induced by intracere-broventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinol 1988; 122: 1773–1778
   PubMedGoogle Scholar
• Brown S L, Smith L R, Blalock J E. Interleukin-1 and interleukin-2 enhance proopiomelanocortin gene expression in pituitary cells. J Immunol 1987; 139: 3181–3183
   Google Scholar
• Roh M S, Drazenovich K A, Barbose J J, Dinarello C A, Cobb C F. Direct stimulation of the adrenal cortex by interleukin-1. Surgery 1987; 102: 140–146
   PubMed Web of Science ®Google Scholar
• Krymskaya L G, Gromykhina N Y, Kozlov V A. Interleukin 1 effect on adrenal gland function in mice. Immunol Lett 1987; 15: 307–309
   Google Scholar
• Whitcomb R W, Linehan W M, Wahl L M, Knazek R A. Monocytes stimulate Cortisol production by cultured human adrenocortical cells. J Clin Endocrinol Metab 1988; 66: 33–38
   PubMed Web of Science ®Google Scholar
• Knudsen P J, Dinarello C A, Strom T B. Glucocorticoids inhibit transcriptional and posttranscriptional expression on interleukin 1 in U937 cells. J Immunol 1987; 4129–4134
   Google Scholar
• Lee S W, Tsou A P, Chan H, Thomas J, Petrie K, Eugui E M, Allison A C. Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 1988; 85: 1204–1208
   PubMed Web of Science ®Google Scholar
• Cannon J G, Evans W J, Hughes V A, Meredith C N, Dinarello C A. Physiological mechanisms contributing to increased interleukin-1 secretion. J Appl Physiol 1986; 61: 1869–1874
   PubMed Web of Science ®Google Scholar
• Akahoshi T, Oppenheim J J, Matsushima K. Induction of high-affinity interleukin-1 receptor on human peripheral blood lymphocytes by glucocorticoid hormones. J Exp Med 1988; 167: 924–936
   PubMedGoogle Scholar
• Hill M R, Stith R D, McCallum R E. Human recombinant IL-1 alters glucocorticoid receptor function in Reuber hepatoma cells. J Immunol 1988; 141: 1522–1528
   PubMed Web of Science ®Google Scholar
• Rasmussen Å K, Bech K, Feldt-Rasmussen U, Poulsen S, Siersbæk-Nielsen K, Friis T, Bendtzen K. The influence of interleukin-1 on the function of in vitro cultured hyman thyroid cells in monolayer. Acta Endocrinol (Copenh) 1987, suppl 281: 93–95
   Google Scholar
• Ozawa M, Sato K, Chol D, Kawakami M, Tsushima T, Shizume K. Effects of tumor necrosis factor-α/cachecin on thyroid hormone metabolism in mice. Endocrinol 1988; 123: 1461–1467
   PubMed Web of Science ®Google Scholar
• Bendtzen K, Rasmussen A K, Bech K, Feldt-Rasmussen U, Egeberg J. Cytokines in autoimmunity. Immunol Today 1987; 8: 203–204
   PubMedGoogle Scholar
• McLachlan S M, Pegg C AS, Atherton M C, Middleton S L, Dickinson A, Clark F, Smith B R. The thyroid microenvironment in autoimmune thyroid disease: Effects of TSH and lymphokines on thyroid lymphocytes and thyroid cells. Acta Endocrinol (Copenh) 1987, suppl. 281: 125–132
   Google Scholar
• Halme J, Hammond M G, Syrop C H, Talbert L M. Peritoneal macrophages modulate human granulosa-luteal cell progesterone production. J Clin Endocrinol Metab 1985; 61: 912–916
   Google Scholar
• Gottschall P E, Uehara A, Hoffman S T, Arimura A. Interleukin-1 inhibits follicle stimulating hormone-induced differentiation in rat granulosa cells in vitro. Biochem Biophys Res Commun 1987; 149: 502–509
   Google Scholar
• Fukuoka M, Mori T, Taii S, Yasuda K. Interleukin-1 inhibits luteinization of porcine granulosa cells in culture. Endocrinol 1988; 122: 367–369
   Google Scholar
• Gottschall P E, Katsuura G, Hoffman S T, Arimura A. Interleukin 1: an inhibitor of luteinizing hormone receptor formation in cultured rat granulosa cells. FASEB J 1988; 2: 2492–2496
   Google Scholar
• Calkins J H, Siegel M M, Nankin H R, Lin T. Interleukin-1 inhibits Leydig cell steroidogenesis in primary culture. Endocrinol 1988; 123: 1605–1610
   PubMed Web of Science ®Google Scholar
• Verhoeven G, Cailleau J, Van Damme J, Billiau A. Interleukin-1 stimulates steroidogenesis in cultured rat Leydig cells. Mol Cell Endocrinol 1988; 57: 51–60
   PubMed Web of Science ®Google Scholar
• Onozaki K, Matsushima K, Aggarwal B B, Oppenheim J J. Human interleukin 1 is a cytocidal factor for several tumor cell lines. J. Immunol 1985; 135: 3962–3968
   PubMed Web of Science ®Google Scholar
• Lachman L B, Dinarello C A, Llansa N D, Fidler I J. Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells. J Immunol 1986; 136: 3098–3102
   PubMed Web of Science ®Google Scholar
• Norioka K, Hara M, Kitani A, Hirose T, Haigai M, Suzuki K, Kawakami M, Tabata H, Kawagoe M, Nakamura H. Inhibitory effect of human recombinant interleukin-1-α and β on growth of human vascular endothelial cells. Biochem Biophys Res Comm 1987; 145: 969–975
   PubMed Web of Science ®Google Scholar
• Cavender D, Haskard D, Foster N, Ziff M. Superinduction of T lymphocyte endothelial cell (EC) binding by treatment of EC with interleukin 1 and protein synthesis inhibitors. J Immunol 1987; 138: 2149–2154
   Google Scholar
• Fakih H, Baggett B, Holtz G, Tsang K-Y, Lee J C, Williamson H O. Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 1987; 47: 213–217
   PubMed Web of Science ®Google Scholar
• Ruggiero V, Baglioni C. Synergistic anti-proliferative activity of interleukin I and tumor necrosis factor. J Immunol 1987; 138: 661–663
   PubMed Web of Science ®Google Scholar
• Eastgate J A, Symons J A, Wood N, Grinlinton F M, Di Giovine F S, Duff G W. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988; ii: 706–709
   Google Scholar
• Maury C PJ, Teppo A M. Serum immunoreactive interleukin 1 in renal transplant recipients. Association of raised levels with graft rejection episodes. Transplantation 1988; 45: 143–147
   Google Scholar
• Michie H R, Manogue K R, Spriggs D R, Revhaug A, O'Dwyer S, Dinarello C A, Cerami A, Wolff S M, Wilmore D W. Detection of circulating tumor necrosis factor after endotoxin administration. TV Engl J Med 1988; 318: 1481–1486
   PubMed Web of Science ®Google Scholar